UV Germi S.A.

UV Germi S.A.

ALUVI.PA
UV Germi S.A.undefined flagEuronext Paris
2.44
EUR
+0.02
- -
7.82MMarket Cap
UV Germi S.A.
ALUVI.PA
(Euronext Paris)

Recent

price

2.44

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
1.45
1.85
1.92
1.85
2
2.4
2.59
2.47
2.31
2.53
- -
2.83
Revenue per Share
0.06
-0.04
-0.1
-0.07
-0.14
0.04
0.16
-0.34
0.02
0.09
- -
0.04
Basic EPS, GAAP
-0.18
-0.12
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.09
-0.01
-0.07
0.08
0.01
0.04
0.2
-0.15
-0.08
0.02
- -
0.24
Book Value per Share
0.66
0.75
0.6
2.39
2.25
2.28
2.34
2.01
2.66
2.55
- -
3.64
Tangible Book Value per Share
2
2
2
3
3
3
3
3
3
3
- -
2
Basic Weighted Avg Shares
3
4
4
5
5
6
7
6
7
8
9
7
Sales/Revenue/Turnover
1.02
-4.58
-7.78
-5.39
-8.46
-1.32
1.46
-15.51
1.93
6.96
6.68
1.34
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
-1
- -
- -
1
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
4.04
-2.31
-5.43
-3.92
-7.01
1.55
6.16
-13.76
0.92
3.61
8.34
1.49
Profit Margin (%)
1
2
2
6
6
5
5
5
8
8
8
8
Working Capital
- -
1
1
1
1
1
1
1
1
- -
- -
- -
LT Debt
2
2
2
7
6
6
7
6
9
9
10
10
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
-337.77
154.74
130.34
- -
- -
- -
168.02
14.87
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
32.09%
10.15%
0.56%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
39.71%
-4.19%
-85.73%
Sales/Revenue/Turnover
5.38%
1.26%
-20.05%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
8
2024
- -
- -
- -
- -
9
2025
- -
- -
- -
- -
7

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.09
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.04

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
UV Germi SA designs, manufactures, and sells ultraviolet (UV) devices primarily for the treatment and depollution of air, water, and surfaces. Its product portfolio includes UV reactors and sterilizers targeting various applications such as drinking water, seawater, dechloramination, wastewater and industrial process water, private pools, legionella control, Germiserre systems, industrial clean water, and livestock farming industries. The company also provides comprehensive after-sales services including installation, online repairs, technical advice, diagnostics, spare parts, on-site intervention, and user training. Founded in 2009 and headquartered in Saint-Viance, France, UV Germi operates mainly within France where approximately 85% of net sales derive. A significant recent operational change includes the acquisition of a 24.38% stake by CEO Willy Fortunato from founding family members. The company emphasizes continuous R&D innovation to enhance the environmental efficacy and performance of its UV treatment technologies, which are entirely manufactured in France, and has positioned itself as a provider of environmentally sensitive solutions without chemical usage. UV Germi serves diverse markets including households, local authorities, and industry sectors with a strategic focus on purifying air, disinfecting water, and sanitizing surfaces across multiple industrial and environmental segments. Recent developments also include broadening offerings in wastewater recycling technologies suitable for irrigation and reinforcing its environmental impact goals through proprietary non-toxic UV platforms. The company is listed on Euronext Paris under ticker ALUVI.PA.